The Medication Quantification Scale 4.0: An Updated Index Based on Prescribers' Perceptions of the Risk Associated With Chronic Pain Medications
The Journal of Pain · 2024
DOI: 10.1016/j.jpain.2023.09.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pain, 2024. Verfasst von Gwenaelle De Clifford-Faugère und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, Quebec, Canada. Hauptthemen laut MEDLINE: Chronic Pain, Physicians. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé.
Themen: Schmerzmanagement
Abstract (Originalsprache)
To quantify risks associated with drug utilization in the real world for the treatment of chronic pain (CP), an index called the Medication Quantification Scale (MQS) was developed in 1992 in the United States and last updated in 2003. This study aimed to update, adapt to the contemporary Canadian context, and validate a revised version of the MQS (the MQS-4.0). Step 1: An expert committee adapted the MQS to the Canadian clinical practice context. Step 2: An update of risk weights given to medication subclasses was achieved using a prescriber survey (weights were derived from median 0-10 scores given to each subclass). Step 3: Construct validity of the MQS-4.0 was assessed after applying risk weights to the medication use profile of persons living with CP covered by public drug insurance plan. Thirty-six medication subclasses were included in the MQS-4.0. A total of 207 prescribers (physicians, pharmacists, and nurse practitioners) participated in the perception survey; 10.63% identified as pain specialists. When risk weights were applied to prescription claims (n = 9,122), the MQS-4.0 score was associated (P < .05) with the MQS-III score and variables associated with polypharmacy (eg, Charlson Comorbidity Index, number of prescribers or health care visits). This study provides an updated index intended for adult populations based on prescribers' perceptions of the risk associated with CP medications that can be useful for clinical practice and research among persons living with CP in Canada. It will, however, be relevant to verify whether similar risk weights are obtained in future pain specialist surveys. PERSPECTIVE: The MQS-4.0 is an update of the MQS used for quantifying the risk associated with the use of analgesics/coanalgesics. Adequate psychometrics properties were found.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, Quebec, Canada.
- Research Center, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Québec, Canada; Faculty of Pharmacy, Université Laval, Québec, Québec, Canada.
- Research Center, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Department of Anesthesiology and Pain Medicine, Université de Montréal, Montreal, Quebec, Canada.
- Department of Physical Medicine and Rehabilitation and Department of Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
- Person with lived experience, Chronic Pain Epidemiology Chair, Université du Québec en Abitibi-Témiscamingue, Rouyn-Noranda, Quebec, Canada.
- Department of Anesthesiology and Pain Medicine, Université de Montréal, Montreal, Quebec, Canada; Pain Clinic, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Förderung
- CIHR
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec - Santé
- Fondation de l’Université du Québec en Abitibi-Témiscamingue
- Réseau Québécois de Recherche sur les Médicaments
- Université de Montréal
- Réseau québécois de recherche sur la douleur
- Fondation de l’Université Laval
Zitieren
APA
De Clifford-Faugère, G., Nguena Nguefack, H. L., Godbout-Parent, M., Diallo, M. A., Guénette, L., Gabrielle Pagé, M., Choinière, M., Harden, R. N., Beaudoin, S., Boulanger, A., Pinard, A. M., Lussier, D., De Grandpré, P., Deslauriers, S., & Lacasse, A. (2024). The Medication Quantification Scale 4.0: An Updated Index Based on Prescribers' Perceptions of the Risk Associated With Chronic Pain Medications. The Journal of Pain. https://doi.org/10.1016/j.jpain.2023.09.010
Vancouver
De Clifford-Faugère G, Nguena Nguefack HL, Godbout-Parent M, Diallo MA, Guénette L, Gabrielle Pagé M, et al. The Medication Quantification Scale 4.0: An Updated Index Based on Prescribers' Perceptions of the Risk Associated With Chronic Pain Medications. The Journal of Pain. 2024. doi:10.1016/j.jpain.2023.09.010
BibTeX
@article{DeCliffordFaugre2024,
author = {De Clifford-Faugère, Gwenaelle and Nguena Nguefack, Hermine Lore and Godbout-Parent, Marimée and Diallo, Mamadou Aliou and Guénette, Line and Gabrielle Pagé, M and Choinière, Manon and Harden, Robert Norman and Beaudoin, Sylvie and Boulanger, Aline and Pinard, Anne Marie and Lussier, David and De Grandpré, Philippe and Deslauriers, Simon and Lacasse, Anaïs},
title = {The Medication Quantification Scale 4.0: An Updated Index Based on Prescribers' Perceptions of the Risk Associated With Chronic Pain Medications},
journal = {The Journal of Pain},
year = {2024},
doi = {10.1016/j.jpain.2023.09.010}
}
EUVIMED